Condition

Solid Cancer clinical trials and research

• 13Clinical trials
• 1NIH research projects
• 20Countries

Newest Solid Cancer clinical trials

All recruiting trials (13)

• AK138D1 for advanced solid tumors

  We will try AK138D1 given by IV in adults with advanced solid tumors that haven't responded to standard treatments to find a safe dose and see if it can shrink tumors.

  Recruiting Phase 1 Akeso · Harbin, Heilongjiang · NCT07281326

• PRaG-1 Plus PRaG Therapy with Radiation and Immunotherapy in Older Adults with Advanced Solid Tumors

  This study tests whether giving PRaG-1 Cordycepin tablets together with radiation, immune-boosting injections, and PD-1/PD-L1 inhibitors can help people aged 65 and older with advanced solid tumors.

  Recruiting Phase 2 Second Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07267234

• Cordycepin (PRaG-1) to raise CD8+ T‑cell counts after treatment for solid tumors

  This trial will test whether PRaG-1 (cordycepin) can raise low CD8+ T‑cell counts in adults who are tumor‑free after treatment for solid cancers.

  Recruiting Phase 2 Second Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07258160

• TC-G203 treatment for GPC3-positive advanced solid tumors

  This trial will test a single-dose TC-G203 cell therapy to see if it is safe and helps adults with GPC3-positive recurrent or metastatic solid tumors who have already tried other treatments.

  Recruiting Early Phase 1 Beijing GoBroad Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07242417

• Urolithin A (MitoPure®) with immune checkpoint inhibitors for newly diagnosed solid tumors

  This trial tests whether taking urolithin A (MitoPure®) alongside first-line immune checkpoint inhibitor therapy changes immune responses in adults with newly diagnosed solid tumors.

  Recruiting Goethe University · Frankfurt · NCT07161310

• How the CES1 liver enzyme affects capecitabine levels in people with colorectal, gastric, or esophageal cancer

  This project will see if differences in the CES1 enzyme change how capecitabine is processed and whether that affects side effects like hand‑foot syndrome in adults starting capecitabine with oxaliplatin for colorectal, gastric, or esophageal cancer.

  Recruiting Erasmus Medical Center · Rotterdam · NCT07114627

• Evaluating the role of radiology manipulators in cancer imaging interpretation

  This study is testing if a new tool can help doctors read cancer imaging better and faster by checking their work before they make a final report.

  Recruiting Institut Paoli-Calmettes · Marseille, Institut Paoli Calmettes · NCT06894082

• Decentralized care pathway for cancer patients receiving oral treatment

  This study is testing a new way for cancer patients on oral chemotherapy to receive care at home from a nurse instead of going to the hospital, to see if it makes them happier and helps them stick to their treatment.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06797037

• Testing HS-20124 for advanced solid tumors

  This study is testing a new treatment called HS-20124 to see if it can help people with advanced solid tumors feel better and fight their cancer.

  Recruiting Phase 1 Hansoh BioMedical R&D Company · Shanghai, Shanghai Municipality · NCT06763159

• Testing AK138D1 for advanced solid tumors

  This study is testing a new treatment called AK138D1 to see if it is safe and effective for people with advanced solid tumors.

  Recruiting at 2 sites Phase 1 Akeso · Blacktown, New South Wales and 3 other locations · NCT06730386

• Evaluating a new injection combined with PD-1 for advanced solid tumors

  This study is testing a new injection combined with PD-1 therapy to see if it can help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting Early Phase 1 Suzhou BlueHorse Therapeutics Co., Ltd. · China, Tianjin Municipality · NCT06697665

• Raludotatug Deruxtecan (R-DXd) for platinum-resistant high-grade ovarian, fallopian tube, and primary peritoneal cancer

  This trial will test whether R-DXd helps people with platinum-resistant high-grade ovarian, fallopian tube, or primary peritoneal cancer who have stopped responding to platinum chemotherapy.

  Recruiting at 29 sites Phase 2/3 Daiichi Sankyo · Anchorage, Alaska and 166 other locations · NCT06161025

• Assessment of elderly cancer patients' needs

  This study looks at how to better support older cancer patients by checking their overall health and needs to help doctors create the best treatment plans for them.

  Recruiting Assistance Publique - Hôpitaux de Paris · Créteil · NCT02884375

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Tailoring iNKT Receptors to Improve Off-the-Shelf CAR Therapies for Solid Cancers

  A science team is improving off-the-shelf iNKT CAR therapies to treat solid tumors by optimizing the receptors that guide these immune cells.

  NIH research University of Pennsylvania · Philadelphia, United States · NIH-11449786

Related topics

Quick answers

How many Solid Cancer clinical trials are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in China (7 trials), France (4 trials), Germany (2 trials), Australia (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 2, Early Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →